Double Heterozygous Mutations (Cys247Tyr and 252delAsn) Cause Factor XII Deficiency in a Chinese Family

Abstract

Objective To study the molecular basis of human coagulation factor XII (FXII) deficiency in a Chinese family.

Methods Routine blood coagulation indexes were detected by a one-stage clotting method, whereas FXII antigen was detected by enzyme linked immunosorbent assay. DNA sequencing was applied to find mutations in the F12 gene. Bioinformatics and conservative analyses were performed to analyze possible effects of the mutation.

Results The proband had significantly prolonged activated partial thromboplastin time (141.9 seconds), and her FXII clotting activity was decreased to 5%. Genetic analysis revealed that the propositus carried a heterozygous missense mutation c.797G > A in exon 8 resulting in Cys247Tyr and deletion mutation c.809_811delACA in exon 9 resulting in 252delAsn. Bioinformatics results indicated that the mutation had affected the function of the protein.

Conclusion The c.797G > A heterozygous missense variation and the c.809_811delACA heterozygous deletion variation are associated with decreased FXII levels in this family, of which c.797G > A is first reported in the world.

Keywords

coagulation FXII deficiency - genetic analysis - F12 gene - gene mutation

Publication History

Received: 23 March 2020

Accepted: 18 May 2020

Article published online:
11 September 2020

• References

• 1 Björkqvist J, Nickel KF, Stavrou E, Renné T. In vivo activation and functions of the protease factor XII. ThrombHaemost 2014; 112 (05) 868-875
• 2 Iijima K, Arakawa Y, Sugahara Y. et al. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity. ThrombHaemost 2011; 105 (03) 473-478
• 3 Cheng X, Yang L, Huang G, Jin Y, Hao X, Wang M. Genetic analysis of a hereditary factor XII deficiency pedigree of a consanguineous marriage due to a homozygous F12 gene mutation: Gly341Arg. Hematology 2017; 22 (05) 310-315
• 4 Didiasova M, Wujak L, Schaefer L, Wygrecka M. Factor XII in coagulation, inflammation and beyond. Cell Signal 2018; 51: 257-265
• 5 Cool DE, MacGillivray RT. Characterization of the human blood coagulation factor XII gene. Intron/exon gene organization and analysis of the 5′-flanking region. J Biol Chem 1987; 262 (28) 13662-13673
• 6 Müller F, Renné T. Novel roles for factor XII-driven plasma contact activation system. CurrOpinHematol 2008; 15 (05) 516-521
• 7 Schmaier AH. Physiologic activities of the contact activation system. Thromb Res 2014; 133 (Suppl. 01) S41-S44
• 8 Joseph K, Kaplan AP. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 2005; 86: 159-208
• 9 de Maat S, Tersteeg C, Herczenik E, Maas C. Tracking down contact activation - from coagulation in vitro to inflammation in vivo. Int J Lab Hematol 2014; 36 (03) 374-381
• 10 Kanaji T, Kanaji S, Osaki K. et al. Identification and characterization of two novel mutations (Q421 K and R123P) in congenital factor XII deficiency. ThrombHaemost 2001; 86 (06) 1409-1415
• 11 Kanaji T, Okamura T, Osaki K. et al. A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998; 91 (06) 2010-2014
• 12 Oguchi S, Ishii K, Moriki T. et al. Factor XII Shizuoka, a novel mutation (Ala392Thr) identified and characterized in a patient with congenital coagulation factor XII deficiency. Thromb Res 2005; 115 (03) 191-197
• 13 Lombardi AM, Bortoletto E, Scarparo P, Scapin M, Santarossa L, Girolami A. Genetic study in patients with factor XII deficiency: a report of three new mutations exon 13 (Q501STOP), exon 14 (P547L) and -13C>T promoter region in three compound heterozygotes. Blood Coagul Fibrinolysis 2008; 19 (07) 639-643
• 14 Yang L, Wang Y, Zhou J. et al. Identification of genetic defects underlying FXII deficiency in four unrelated Chinese patients. Acta Haematol 2016; 135 (04) 238-240
• 15 Jin P, Jiang W, Yan H. et al. Novel mutations in congenital factor XII deficiency. Front Biosci 2016; 21: 419-429
• 16 Hofman ZLM, Clark CC, Sanrattana W. et al. A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation. J Biol Chem 2020; 295 (02) 363-374